Physician profile
James Cao
NPI 1346328325
$550.84
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.58 · 2022: $317 · 2023: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $136.16 | 2023 | Empaveli |
| Amgen INC. | $82.45 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $51.72 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $37.61 | 2022 | |
| Genzyme Corporation | $35.25 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $22.01 | 2022 | |
| Glaxosmithkline, LLC. | $20.87 | 2022 | |
| Myovant Sciences INC. | $20.06 | 2022 | |
| Blueprint Medicines Corporation | $19.66 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.24 | 2022 | |
| Janssen Biotech, INC. | $18.17 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.46 | 2022 | |
| Genentech USA, INC. | $15.07 | 2022 | |
| Emd Serono, INC. | $14.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.95 | 2022 | |
| Kyowa Kirin, INC. | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.